AZB & Partners advised SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals
Investment from SK Capital to support Apotex’s next phase of growth and continued innovation for patient affordability.
An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) announced that it has reached an agreement to acquire Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”), a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines across all major therapeutic areas for patients around the world.
AZB & Partners advised SK Capital. The AZB & Partners team comprised of Partners, Ashwath Rau and Jasmin Karkhanis and Senior Associates, Saras Muzumdar, Nitika Jain and Rashmee Kumar.
Write to us at [email protected]